Neonatal jaundice, unspecified. Physiological jaundice (intense)(prolonged) NOS
Conditions
Interventions
Intervention 1: Intervention group : In the intervention group, the researcher will be massaged the infants twice a day on five consecutive days. Before the intervention, transcutaneous bilirubin leve
From the shoulders down the arms to the wrist, and vice versa. In the middle phase, the neonate will make to lie in a supine position for kinesthetic stimulation that included 5 segments of 1 minute e
Intervention group : In the intervention group, the researcher will be massaged the infants twice a day on five consecutive days. Before the intervention, transcutaneous bilirubin levels are determine
From the thighs down to the ankles, and
The control group: Infants in the control group will receive routine care and no intervention will be performed on them.
Sponsors
Research deputy of Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
7 Months to 8 Months
Inclusion criteria
Inclusion criteria: Inclusion criteria: stabilization of neonate's condition (12-24 hours after birth), Apgar score 7 or more, gestational age 30-36 weeks, weighing more than 1250 g, 5th minutes after birth Apgar score 7 or more, lack of any massage contraindication (like wound, skin lesions, burn, ecchymosis, fracture or joint dislocation, infectious rush and hyperthermia), lack of obvious congenital anomalies, absence of congenital infection Exclusion criteria: getting neonatal clinical Icter after 24 hours after birth, any proof of known causes of jaundice like: Glucose-6-phosphate dehydrogenase deficiency, hypothyroidism, RH or ABO incompatibility or any evidence of erythrocytes lysis, getting phototherapy, blood transfusion and medication (drugs such as intravenous Immunoglobulin, Metalloporphyrins and Clofibrate) for jaundice a day after birth, Infection during the study (blood culture or cerebrospinal fluid culture - positive CSF).
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Skin bilirubin levels. Timepoint: Before the intervention, and then daily until the tenth day or discharged date. Method of measurement: in mg/dl with transcutaneous bilirubinometry. | — |
Secondary
| Measure | Time frame |
|---|---|
| Stool frequency. Timepoint: daily until the tenth day or discharged date. Method of measurement: Depending on the number recorded in the infants’ files. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSoheila Karbandi
Mashhad University of Medical Sciences
Outcome results
None listed